These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 13357692)

  • 21. [Research on the natural immunity to infection by gramnegative bacteria. The properdin system as a mechanism of natural immunity. Relationship between nonspecific immune defenses and the properdin system. Note I].
    BO G
    Boll Ist Sieroter Milan; 1960; 39():151-62. PubMed ID: 13801764
    [No Abstract]   [Full Text] [Related]  

  • 22. Lethal outcome caused by Porphyromonas gingivalis A7436 in a mouse chamber model is associated with elevated titers of host serum interferon-gamma.
    Huang JH; Lin YY; Lai YY; Hu SW
    Oral Microbiol Immunol; 2006 Apr; 21(2):100-6. PubMed ID: 16476019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of endotoxin on resistance to infection and disease.
    Berger FM
    Adv Pharmacol (1962); 1967; 5():19-46. PubMed ID: 4864477
    [No Abstract]   [Full Text] [Related]  

  • 24. Reversible changes in the susceptibility of mice to bacterial infections. I. Changes brought about by injection of pertussis vaccine or of bacterial endotoxins.
    DUBOS RJ; SCHAEDLER RW
    J Exp Med; 1956 Jul; 104(1):53-65. PubMed ID: 13332180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Similarity of host responses elicited by polysaccharides of animal and plant origin and by bacterial endotoxins.
    LANDY M; SHEAR MJ
    J Exp Med; 1957 Jul; 106(1):77-97. PubMed ID: 13439117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Properdin and the defence of burns against infection.
    LOWBURY EJ; RICKETTS CR
    J Hyg (Lond); 1957 Jun; 55(2):266-75. PubMed ID: 13439176
    [No Abstract]   [Full Text] [Related]  

  • 27. The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against gram-negative bacteria and lipopolysaccharide.
    Elsbach P; Weiss J
    Immunobiology; 1993 Apr; 187(3-5):417-29. PubMed ID: 8330906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Properdin, a serum factor of importance for natural resistance].
    BRO-RASMUSSEN F; KILLMANN SA
    Nord Med; 1956 Oct; 56(41):1479-82. PubMed ID: 13388106
    [No Abstract]   [Full Text] [Related]  

  • 29. Mechanisms of endotoxin shock and endotoxin hypersensitivity.
    Galanos C; Freudenberg MA
    Immunobiology; 1993 Apr; 187(3-5):346-56. PubMed ID: 8330903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Changes in certain plasma factors of natural defense system in dogs under the influence of bacterial lipopolysaccharide].
    Klimova KN; Ivanova NM
    Biull Eksp Biol Med; 1966 Sep; 62(9):80-2. PubMed ID: 6005403
    [No Abstract]   [Full Text] [Related]  

  • 31. The properdin system and immunity. XV. Some biologic effects of the administration of zvmosan and other polvsaccharides to rabbits, and the presence of antibodies to zymosan in human and rabbit serum.
    HINZ CF; WEDGWOOD RJ; PILLEMER L
    J Lab Clin Med; 1961 Feb; 57():185-98. PubMed ID: 13714488
    [No Abstract]   [Full Text] [Related]  

  • 32. Termination of tolerance to human gamma globulin in mice by antigen and bacterial lipopolysaccharide (endotoxin).
    Chiller JM; Weigle WO
    J Exp Med; 1973 Mar; 137(3):740-50. PubMed ID: 4120288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibiotic induced endotoxin release and clinical sepsis: a review.
    Holzheimer RG
    J Chemother; 2001 Nov; 13 Spec No 1(1):159-72. PubMed ID: 11936361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virulence attributes of the liposaccharides of the HAP group organisms.
    Fenwick BW
    Can J Vet Res; 1990 Apr; 54 Suppl():S28-32. PubMed ID: 2193700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.
    Calandra T; Baumgartner JD; Glauser MP
    Prog Clin Biol Res; 1991; 367():141-59. PubMed ID: 1924424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Host resistance in hemorrhagic shock. VIII. Effect of properdin on in vitro function of phagocytes.
    RUTENBURG SH; FINE J
    Proc Soc Exp Biol Med; 1957 Jul; 95(3):446-8. PubMed ID: 13453463
    [No Abstract]   [Full Text] [Related]  

  • 37. Antigenic homology of endotoxin with a coliform mastitis vaccine strain, Escherichia coli O111:B4 (J5).
    Tyler JW; Spears H; Nelson R
    J Dairy Sci; 1992 Jul; 75(7):1821-5. PubMed ID: 1500577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative studies on the properdin-complement system.
    LEON MA
    J Exp Med; 1956 Mar; 103(3):285-93. PubMed ID: 13295486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bacterial endotoxins: relationship between chemical structure and biological effect].
    Rietschel ET; Brade L; Schade FU; Seydel U; Zähringer U; Mamat U; Schmidt G; Ulmer AJ; Loppnow H; Flad HD
    Immun Infekt; 1993 Apr; 21(2):26-35. PubMed ID: 8340135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in the titre of serum opsonins and phagocytic properties of mouse peritoneal macrophages following injection of endotoxin.
    JENKIN C; PALMER DL
    J Exp Med; 1960 Aug; 112(2):419-29. PubMed ID: 13789821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.